Predicting the Impact of Vaccination on the Transmission Dynamics of Typhoid in South Asia: A Mathematical Modeling Study

PLoS Neglected Tropical Diseases

Volumn 8, Issue 1, 2014, Pages 40-

  Pitzer, Virginia E ^a,b   Bowles, Cayley C ^c,d   Baker, Stephen ^e,f,g   Kang, Gagandeep ^h   Balaji, Veeraraghavan ^h   Farrar, Jeremy J ^d,e,f   Grenfell, Bryan T ^b,d  

^a YALE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d PRINCETON UNIVERSITY   (United States)

^e OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^f UNIVERSITY OF OXFORD   (United Kingdom)

^g LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^h CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

TYPHOID VACCINE; TYPHOID PARATYPHOID VACCINE;

ADOLESCENT; ARTICLE; CHILD; DISEASE TRANSMISSION; DRUG EFFICACY; HUMAN; IMMUNITY; INFANT; MATHEMATICAL MODEL; MORBIDITY; PREDICTION; SANITATION; SOUTH ASIA; TYPHOID FEVER; VACCINATION; VALIDATION PROCESS; ADULT; AGE DISTRIBUTION; AGED; ASIA; BASIC REPRODUCTION NUMBER; HETEROZYGOTE; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; PRESCHOOL CHILD; THEORETICAL MODEL; UTILIZATION REVIEW; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ASIA; BASIC REPRODUCTION NUMBER; CARRIER STATE; CHILD; CHILD, PRESCHOOL; DISEASE TRANSMISSION, INFECTIOUS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MODELS, THEORETICAL; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES; VACCINATION; YOUNG ADULT;

EID: 84893715442     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002642     Document Type: Article

References (37)

1. Crump JA, Luby SP, Mintz ED, (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346-353.
2. Buckle G, Walker C, Black R, (2012) Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010. J Glob Health 2: 1-9.
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128 doi:10.1016/S0140-6736(12)61728-0.
4. Ochiai RL, Acosta CJ, Danovaro-Holliday MC, Baiqing D, Bhattacharya SK, et al. (2008) A study of typhoid fever in five Asian countries: disease burden and implications for controls. Bull World Health Organ 86: 260-268 doi:10.2471/BLT.06.039818.
5. Roumagnac P, Weill F-X, Dolecek C, Baker S, Brisse S, et al. (2006) Evolutionary history of Salmonella typhi. Science (80-) 314: 1301-1304 doi:10.1126/science.1134933.
6. WHO (2008) Typhoid vaccines: position paper. Wkly Epidemiol Rec 83: 49-60.
7. Bodhidatta L, Taylor DN, Thisyakorn U, Echeverria P, (1987) Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine. Rev Infect Dis 9: 841-845.
8. DeRoeck D, Ochiai R, Yang J, Ahn DD, Alag V, et al. (2008) Typhoid vaccination: the Asian experience. Expert Rev Vaccines 5: 547-560.
9. Fraser A, Goldberg E, Acosta C (2009) Vaccines for preventing typhoid fever (Review). The Cochrane Library. Chichester: John Wiley & Sons.
10. Levine M, Ferreccio C, (1989) Progress in vaccines against typhoid fever. Rev Infect Dis 11: S552-S567.
11. Robbins JD, Robbins JB, (1984) Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis 150: 436-449.
12. Levine M, Black R, Ferreccio C, Germanier R, (1987) Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet 8541: 1049-1052.
13. Acharya I, Lowe C, (1987) Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Samonella typhi. N Engl J Med 317: 1101-1104.
14. Lin F, Ho V, Khiem H, (2001) The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 344: 1263-1269.
15. Lanh MN, Van Bay P, Ho VA, Tran CT, Lin FYC, et al. (2003) Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med 349: 1390-1391 doi:10.1056/NEJM200310023491423.
16. Sur D, Ochiai RL, Bhattacharya SK, Ganguly NK, Ali M, et al. (2009) A cluster-randomized effectiveness trial of Vi typhoid vaccine in India. N Engl J Med 361: 335-344.
17. Khan MI, Soofi SB, Ochiai RL, Habib MA, Sahito SM, et al. (2012) Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan. Vaccine 30: 5389-5395 doi:10.1016/j.vaccine.2012.06.015.
18. Cvjetanović B, Grab B, Uemura K, (1971) Epidemiological model of typhoid fever and its use in the planning and evaluation of antityphoid immunization and sanitation programmes. Bull World Health Organ 45: 53-75.
19. González-Guzmán J, (1989) An epidemiological model for direct and indirect transmission of typhoid fever. Math Biosci 96: 33-46.
20. Lange H, Ulm K, Raettig H, Huber H, (1983) The effect of various interventions during a typhoid epidemic: Results of a simulation study. Infection 11: 97-103.
21. Saul A, Smith T, Maire N, (2013) Stochastic Simulation of Endemic Salmonella enterica Serovar Typhi: The Importance of Long Lasting Immunity and the Carrier State. PLoS One 8: e74097 doi:10.1371/journal.pone.0074097.
22. Shpargel JS, Berardi RS, Lenz D, (1983) Salmonella typhi carrier state 52 years after illness with typhoid fever: A case study. American Journal of Infection Control 13: 122-123.
23. Sinnott CR, Teall AJ, (1987) Persistent gallbladder carriage of Salmonella typhi. The Lancet 1: 976.
24. Halloran M, Struchiner C, (1991) Study Designs for Dependent Happenings. Epidemiology 2: 331-338.
25. Khatri N, Maskey P, Poudel S, Jaiswal V, Karkey A, et al. (2009) Gallbladder carriage of Salmonella paratyphi A may be an important factor in the increasing incidence of this infection in South Asia. Annals of Internal Medicine 150: 567-568.
26. McLean AR, Anderson RM, (1988) Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect 100: 419-442.
27. Cvjetanović B, Uemura K, (1965) The present status of field and laboratory studies of typhoid and paratyphoid vaccines. Bull World Health Organ 32: 29-36.
28. Baker S, Holt KE, Clements ACA, Karkey A, Arjyal A, et al. (2011) Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission. Open Biol 1: 110008 doi:10.1098/rsob.110008.
29. Saha SK, Baqui AH, Hanif M, Darmstadt GL, Ruhulamin M, et al. (2001) Typhoid fever in Bangladesh: Implications for vaccination policy. Pediatr Infect Dis J 20: 521-524.
30. Hornick R, Greisman S, Woodward TE, Dupont HL, Dawkins AT, et al. (1970) Typhoid fever: Pathogenesis and immunologic control (Part 2). N Engl J Med 283: 739-746.
31. Glynn J, Hornick R, Levine M, Bradley D, (1995) Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used. Epidemiol Infect 115: 23-30.
32. Gonzalez-Escobedo G, Marshall JM, Gunn JS, (2011) Chronic and acute infection of the gall bladder by Salmonella Typhi: understanding the carrier state. Nat Rev Microbiol 9: 9-14.
33. Ames WR, Robins M, (1943) Age and sex as factors in the development of the typhoid carrier state, and a method for estimating carrier prevalence. Am J Public Health 33: 221-230.
34. Stokes A, Clarke C, (1916) A search for typhoid carriers among 800 convalenscents. Lancet pp. 566-569.
35. Levine M, Black R, Lanata C, (1982) Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area. J Infect Dis 146: 724-726.
36. Hornick R, Greisman S, Woodward TE, Dupont HL, Dawkins AT, et al. (1970) Typhoid fever: Pathogenesis and immunologic control (Part 1). N Engl J Med 283: 686-691.
37. Cho JC, Kim SJ, (1999) Viable, but non-culturable, state of a green fluorescence protein-tagged environmental isolate of Salmonella typhi in groundwater and pond water. FEMS Microbiol Lett 170: 257-264.